Organon & Co.

Organon & Co.verified

OGN

Price:

$21.8

Market Cap:

$5.61B

Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypert...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2021-05-14

Stock Exchange

NYSE

Ticker

OGN

The ROE as of May 2024 (TTM) for Organon & Co. (OGN) is -359.18%

According to Organon & Co.’s latest financial reports and current stock price. The company's current ROE is -359.18%. This represents a change of 246.44% compared to the average of -103.68% of the last 4 quarters.

Organon & Co. (OGN) Historical ROE (quarterly & annually)

How has OGN ROE performed in the past?

The mean historical ROE of Organon & Co. over the last ten years is -267.36%. The current -359.18% ROE has changed 34.34% with respect to the historical average. Over the past ten years (40 quarters), OGN's ROE was at its highest in in the March 2024 quarter at 418.75%. The ROE was at its lowest in in the December 2023 quarter at -780.00%.

Quarterly (TTM)
Annual

Average

-267.36%

Median

-89.59%

Minimum

-1461.43%

Maximum

45.74%

Organon & Co. (OGN) ROE by Quarter and Year

Discovering the peaks and valleys of Organon & Co. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 45.74%

Minimum Annual Increase = 0%

Minimum Annual ROE = -1461.43%

Quarterly (TTM)
Annual
YearROEChange
2023-1461.43%1.32%
2022-102.80%14.75%
2021-89.59%-65.99%
2020-263.41%-675.86%
201945.74%Infinity%
20180%0%

Organon & Co. (OGN) Average ROE

How has OGN ROE performed in the past?

The current ROE of Organon & Co. (OGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-551.27%

5-year avg

-374.30%

10-year avg

-267.36%

Organon & Co. (OGN) ROE vs. Peers

How is OGN’s ROE compared to its peers?

Organon & Co.’s ROE is less than Johnson & Johnson (53.97%), greater than Bristol-Myers Squibb Company (-23.01%), less than AbbVie Inc. (55.33%), less than Eli Lilly and Company (53.53%), less than Pfizer Inc. (-0.31%), less than Amgen Inc. (58.59%), less than Merck & Co., Inc. (5.84%), less than Gilead Sciences, Inc. (2.32%), less than Sanofi (9.61%), less than AstraZeneca PLC (16.75%), less than Novartis AG (34.58%), less than Biogen Inc. (7.92%),

CompanyROEMarket cap
53.97%$372.17B
-23.01%$89.25B
55.33%$293.88B
53.53%$731.81B
-0.31%$162.29B
58.59%$167.62B
5.84%$332.28B
2.32%$84.37B
9.61%$111.72B
16.75%$238.43B
34.58%$200.68B
7.92%$33.57B

Build a custom stock screener for Organon & Co. (OGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Organon & Co. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Organon & Co. (OGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Organon & Co. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Organon & Co.'s ROE?

How is the ROE calculated for Organon & Co. (OGN)?

What is the highest ROE for Organon & Co. (OGN)?

What is the 3-year average ROE for Organon & Co. (OGN)?

What is the 5-year average ROE for Organon & Co. (OGN)?

How does the current ROE for Organon & Co. (OGN) compare to its historical average?